Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes.
about
Immunotherapy for brain cancer: recent progress and future promiseHeat shock protein-based therapeutic strategies against human immunodeficiency virus type 1 infection.Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.Cytosolic delivery of granzyme B by bacterial toxins: evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perforin.Existing antilisterial immunity does not inhibit the development of a Listeria monocytogenes-specific primary cytotoxic T-lymphocyte response.Noncompetitive expansion of cytotoxic T lymphocytes specific for different antigens during bacterial infection.Intracellular bacteria as targets and carriers for vaccination.Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors.Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunityHeat shock proteins: novel therapeutic tools for HIV-infection?Directed antigen delivery as a vaccine strategy for an intracellular bacterial pathogen.Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenesAttenuated Listeria monocytogenes vaccine vectors expressing influenza A nucleoprotein: preclinical evaluation and oral inoculation of volunteers.Cytosolic entry controls CD8+-T-cell potency during bacterial infection.Peptide epitopes from noncytosolic Listeria monocytogenes can be presented by major histocompatibility complex class I molecules.Lm-LLO-Based Immunotherapies and HPV-Associated DiseaseBrucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c miceRecombinant Listeria monocytogenes vaccination eliminates papillomavirus-induced tumors and prevents papilloma formation from viral DNAThe next wave of recombinant and synthetic anticancer vaccines.Smart adjuvants.Stable integration vector for nutrient broth-based selection of attenuated Listeria monocytogenes strains with recombinant antigen expressionListeria monocytogenes: a promising vehicle for neonatal vaccination.Generation of branched-chain fatty acids through lipoate-dependent metabolism facilitates intracellular growth of Listeria monocytogenes.Recombinant Listeria monocytogenes expressing a cell wall-associated listeriolysin O is weakly virulent but immunogenic.Cancer immunotherapy using Listeria monocytogenes and listerial virulence factorsListeria-based cancer vaccines that segregate immunogenicity from toxicityMicrobial-based therapy of cancer: current progress and future prospects.Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment.Therapeutic live vaccines as a potential anticancer strategy.Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer.Cancer immunotherapy: moving forward with peptide T cell vaccines.Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes.Liposome-encapsulated antigens induce a protective CTL response against Listeria monocytogenes independent of CD4+ T cell help.Controlling influenza by cytotoxic T-cells: calling for help from destroyers.Attenuated Listeria monocytogenes carrier strains can deliver an HIV-1 gp120 T helper epitope to MHC class II-restricted human CD4+ T cells.Recombinant Listeria monocytogenes as a live vaccine vehicle and a probe for studying cell-mediated immunity.Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease.as a Vector for Cancer Immunotherapy: Current Understanding and Progress
P2860
Q27015881-FC675357-09AD-4961-A8FE-A2181A2321E3Q33609641-C7E9608E-E80D-4A10-B847-6607C0A192E1Q33633839-5AB7C9E2-8EBB-4524-B438-7D2B3CC9B64DQ33960986-22C946AE-6CA9-4003-8C52-8587FE5CEB6EQ34000001-BD552FFA-F503-407B-A7D4-099AF9A58F02Q34000642-2E345FD7-31FA-47D4-B5CD-974C68A192EEQ34280918-9A4406CE-05A1-48C4-80A6-719FC0B75DB3Q34315765-C185ACD7-69FA-4C59-BF26-499D2C3503B8Q34400216-9F55CC2C-D563-41D9-9034-D78D9448A39BQ34452131-57C831F9-CAF5-4455-A11A-122C41703D78Q34596940-DF4E10C3-8C52-4ACB-AA8E-15F8B47DFB4DQ34721021-9FD5311A-FE30-4DB0-B182-948D1E59E2CEQ34861112-222A96CC-1126-46EB-BBB0-118867C7D78BQ35217477-BF9CC306-FB51-4C5F-B459-0FD2000BBD58Q35493417-3A1F6160-248F-480C-AA4E-F9D6D1592C20Q35838127-016AE572-9E68-4AF3-BC54-3BA79A8E89FBQ35860387-8B778F73-2302-4069-A397-42405F35D004Q35898471-5BC64035-8300-4118-805C-A07A9A863AE8Q36470749-AAAB05A6-0E8C-4A77-83EB-1356EB0CF4A4Q36837149-101D0AE9-E0C8-4074-B869-8589D2683FC2Q36897998-CD5DDB8E-2B6B-449A-845E-2937DA33516BQ36977730-520C9666-1172-4301-BAF4-F1A9166AC65AQ37127810-AF23CFEF-583A-455F-90AF-F556FC784917Q37355862-AF563859-6578-4DF6-90EF-E0CEB14E52E5Q37391236-76B7AC09-44CF-4DCF-A201-B6039EE5DCE1Q37535306-3E9B97A8-908D-4544-A393-BE52F9259E7FQ37843621-3D271438-36D4-4C11-8CC4-2D23C61C4D45Q37843660-05D379BB-FFE6-4597-8E26-1D05CF19F611Q38011653-CF710200-04A5-4EE3-8456-6BA58728A4FBQ39340402-9086F9CC-6954-4A53-A926-C750B84C04D0Q39451757-7A0AEB11-C559-4DAA-88AF-81A6975C35AFQ39874289-3CD970C9-AA8A-456C-9277-A89BB0416088Q39988900-4D671761-6AE0-4BD3-AE94-A627B6BD4206Q40730765-0A06F716-DB0E-4ACC-B86F-B44928A45CF0Q41030023-43F9ADD2-5E18-4133-AC4A-8993918D68B3Q41603477-84816377-34AD-45D8-AB30-A5040A3E4BA6Q41603483-FB4A1C65-54EC-4163-9ACD-9263B9A2EC7CQ58924835-63591546-5AEB-41D1-A678-880BEB6F50C4
P2860
Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes.
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Delivery of a viral antigen to ...... way by Listeria monocytogenes.
@ast
Delivery of a viral antigen to ...... way by Listeria monocytogenes.
@en
Delivery of a viral antigen to ...... way by Listeria monocytogenes.
@nl
type
label
Delivery of a viral antigen to ...... way by Listeria monocytogenes.
@ast
Delivery of a viral antigen to ...... way by Listeria monocytogenes.
@en
Delivery of a viral antigen to ...... way by Listeria monocytogenes.
@nl
prefLabel
Delivery of a viral antigen to ...... way by Listeria monocytogenes.
@ast
Delivery of a viral antigen to ...... way by Listeria monocytogenes.
@en
Delivery of a viral antigen to ...... way by Listeria monocytogenes.
@nl
P2093
P2860
P356
P1476
Delivery of a viral antigen to ...... hway by Listeria monocytogenes
@en
P2093
D A Portnoy
G Ikonomidis
P2860
P304
P356
10.1084/JEM.180.6.2209
P407
P577
1994-12-01T00:00:00Z